Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling

Area of Science:

• Comparative genomics
• Bioinformatics
• Cancer research

Background:

• Genome sequencing and gene homology studies enable cross-species differential gene expression analysis.
• Understanding liver cancer in humans can be enhanced by studying animal models.
• Genes with conserved functions are likely co-expressed across species.

Purpose of the Study:

• To elucidate genes, chromosome aberrations, and pathways associated with human liver cancer.
• To utilize microarray expression profiles from albumin-SV40 transgenic rat liver neoplasms.
• To apply bioinformatics approaches for cross-species extrapolation and analysis.

Main Methods:

• Identified 2223 differentially expressed genes using an F-test.
• Mapped genes to rat, human, and mouse chromosomes using a novel visualization tool (Chromosome Plot).
• Performed Comparative Genomics Microarray Analysis (CGMA) and pathway analysis.

Main Results:

• Rat liver cancer genes on chromosome 1q mapped to human chromosomes 10, 11, 19 and mouse chromosomes 7, 17, 19.
• Identified potential chromosomal aberrations in human liver cancer via CGMA.
• Pathway analysis revealed significant alterations in cell cycle, growth, apoptosis, and metabolism, all relevant to human liver cancer.

Conclusions:

• Hepatic gene expression profiles from the rat model reveal conserved genes, pathways, and chromosomal alterations relevant to human liver cancer.
• Bioinformatics tools are crucial for cross-species microarray data analysis and interpretation.
• The findings support the utility of the albumin-SV40 transgenic rat model for liver cancer research.